Most bought healthcare stocks in Q1 2016

See which Healthcare stocks institutional investors increased the most in Q1 2016, measured as net growth in reported share positions from Q4 2015 into Q1 2016. Notable additions at the top of this list include INNOVIVA INC (INVA), ASTRAZENECA PLC-SPONS ADR (AZN), ELI LILLY & CO (LLY), COMMUNITY HEALTH SYSTEMS INC (CYH). These rankings aggregate SEC 13F filings from all institutional investors in our database.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
INVAINNOVIVA INC23,041,974$290.10K20002
AZNASTRAZENECA PLC-SPONS ADR14,989,368$325.00K02013
LLYELI LILLY & CO14,025,346$985.57K12205
CYHCOMMUNITY HEALTH SYSTEMS INC9,102,325$166.88K30013
ZTSZOETIS INC7,909,955$191.38K22005
TEVATEVA PHARMACEUTICAL-SP ADR6,134,209-$39.93K04105
HCAHCA HEALTHCARE INC2,935,923$232.67K11012
HALOHALOZYME THERAPEUTICS INC2,732,800-$7.96K11002
DHRDANAHER CORP2,235,631$1.70M15219
EDITEDITAS MEDICINE INC2,135,523$73.76K10001
IDXXIDEXX LABORATORIES INC2,029,315$173.10K02003
UNHUNITEDHEALTH GROUP INC1,766,132$3.47M253010
DVADAVITA INC1,762,852$294.68K12105
ALGNALIGN TECHNOLOGY INC1,550,687$124.88K11103
BAXBAXTER INTERNATIONAL INC1,542,020$254.42K12428
SYKSTRYKER CORP1,187,582$228.00K12215
PTCTPTC THERAPEUTICS INC948,700$6.11K10001
SNNSMITH & NEPHEW PLC -SPON ADR809,200$26.27K01001
INCYINCYTE CORP767,860$55.65K20002
BMRNBIOMARIN PHARMACEUTICAL INC758,651$53.14K11103
ABBVABBVIE INC731,039-$11.42M22418
OSURORASURE TECHNOLOGIES INC720,700$6.77K01001
CMRXCHIMERIX INC640,388$3.27K10001
DXCMDEXCOM INC610,489$31.75K11002
CPIXCUMBERLAND PHARMACEUTICALS565,411$1.28K02002
ARAYACCURAY INC505,877$71601001
EWEDWARDS LIFESCIENCES CORP478,260$74.63K01102
SGMOSANGAMO THERAPEUTICS INC474,391$1.61K02002
UHSUNIVERSAL HEALTH SERVICES-B467,937$61.44K22004
EXELEXELIXIS INC457,569$92601001
GERNGERON CORP453,480$1.02K10002
BRKRBRUKER CORP441,110$12.35K10001
MDPEDIATRIX MEDICAL GROUP INC438,392$28.32K10011
GILDGILEAD SCIENCES INC424,445$4.46M1103014
THCTENET HEALTHCARE CORP348,405$10.08K10001
GMEDGLOBUS MEDICAL INC - A346,700$8.23K10001
LFCRLIFECORE BIOMEDICAL INC286,407$1.20K01102
AMEDAMEDISYS INC282,600$16.80K01001
AZTAAZENTA INC271,143$2.66K01102
MDXGMIMEDX GROUP INC253,425$2.20K11002
XRAYDENTSPLY SIRONA INC249,215$15.36K10001
ATRAPTARGROUP INC230,400$19.60K01002
ZBHZIMMER BIOMET HOLDINGS INC225,862$34.44K02306
PDCOPATTERSON COS INC224,605$20.82K02104
HCSGHEALTHCARE SERVICES GROUP221,498$8.37K01011
ALNYALNYLAM PHARMACEUTICALS INC211,700$13.22K10011
RGENREPLIGEN CORP200,300$4.22K01001
EXASEXACT SCIENCES CORP197,940$1.30K01001
ENZENZO BIOCHEM INC196,800$95801001
REGNREGENERON PHARMACEUTICALS190,093-$65.20K02002
Net change in reported shares (all institutional filers) by symbol20 symbols with net change in reported shares from all institutional filers.0.006.3M12.7M19.0M25.3MNet change in reported shares (all institutional filers)INVAAZNLLYCYHZTSTEVAHCAHALODHREDITIDXXUNHDVAALGNBAXSYKPTCTSNNINCYBMRNSymbol

Frequently asked questions about Most bought healthcare stocks in Q1 2016

  • What are the most bought Healthcare stocks in Q1 2016?

    The most bought healthcare stocks in Q1 2016 are those with the largest increase in reported share counts across institutional investors compared to Q4 2015, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors added to the most in Q1 2016?

    Among filers in this sector, net additions were largest in companies such as INNOVIVA INC (INVA), ASTRAZENECA PLC-SPONS ADR (AZN), ELI LILLY & CO (LLY), based on aggregated 13F data.

  • How is institutional buying calculated?

    Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2015).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.